Unseen Upside S5:EP1 Investing in Affordable Homes for Healthier Communities

Published on October 17, 2024

Join us as we head to the Bronx to examine the critical intersection of housing and health and the innovative solutions that are aiming to address the affordable housing crisis in major cities like New York and LA.

Through conversations with non-profit leaders and impact investors, we dive into how affordable housing impacts public health and health equity, highlighting the investment strategies and community partnerships that are moving the needle. We also discuss the challenges of housing insecurity and the disproportionate effects on marginalized communities, recognizing affordable housing is a critical determinant of community health.

Guests include:

  • Margaret Anadu, Senior Partner at The Vistria Group
  • Tim Ortez, Vice President & Chief Financial Officer Weingart Foundation, a Cambridge Associates client and also an investor in The Vistria Group
  • Jasmine Richards, Head of Diverse Manager Research at Cambridge Associates

 

Listen to the episode here.

Other news

The Fed Cuts Aggressively, but Remains Cautious About Future Cuts

September 30, 2024
The Federal Reserve has reduced the target range for the federal funds rate by 50 basis points (bps) to 4.75%–5.00%, the first reduction in over four years. This decision, while anticipated, marks a pivotal shift in monetary policy. The Fed also released updated economic projections, which highlighted it expects to reduce interest rates by a total of 200 bps through 2025. That level is less than w

Unseen Upside S5:EP2 Drug Affordability: The High Cost of Healing

October 22, 2024
Prescription drug prices in the United States are 2.78 times higher than in other developed countries, but why?In this podcast episode, we untangle the barriers surrounding drug affordability and find out why accessing life-saving medications is costly to so many. Joined by experts, advocates, and one Cystic Fibrosis patient relying on expensive medication to live, we examine the complex factors c